Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals
TOKYO, June 30, 2025 /PRNewswire/ — Alpha Fusion, Inc. (“Alpha Fusion”) and Curadh MTR Inc. (“Curadh”) announced plans to enter a strategic partnership, including a Joint Venture to broadly advance the global development of Astatine-211… Read More »Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals





